Literature DB >> 9065931

Antibacterial protection of the ocular surface.

U Pleyer1, H Baatz.   

Abstract

The outer surface of the eye is constantly exposed to a wide array of microorganisms. To protect the integrity or the ocular surface and to retain corneal transparency, a number of defense mechanisms have evolved. This article discusses the host mechanisms of the eyelids-, tears, cornea and conjunctiva. These host defense mechanisms are identified as either a native, nonspecific defense or a specifically acquired immunological defense requiring previous exposure to an antigen and the development of specific immunity. Nonspecific components that protect the eye include the eyelids, ocular surface epithelium, normal flora and tear proteins. Specifically acquired immunity in tears, cornea and conjunctiva involves the interaction of antigen-presenting cells, lymphocytes and humoral components of the immune system.

Entities:  

Mesh:

Year:  1997        PMID: 9065931     DOI: 10.1159/000310878

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  9 in total

1.  [Eye-associated lymphoid tissue (EALT) is continuously spread throughout the ocular surface from the lacrimal gland to the lacrimal drainage system].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

2.  Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients.

Authors:  T Hessel; S P Dhital; R Plank; D Dean
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.

Authors:  A P Tarver; D P Clark; G Diamond; J P Russell; H Erdjument-Bromage; P Tempst; K S Cohen; D E Jones; R W Sweeney; M Wines; S Hwang; C L Bevins
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Effects of moxifloxacin exposure on the conjunctival flora and antibiotic resistance profile following repeated intravitreal injections.

Authors:  Mustafa Ataş; Burhan Başkan; Ayşe Ozköse; Fatma Mutlu Sarıgüzel; Süleyman Demircan; Emine Pangal
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

5.  Geographic Difference Shaped Human Ocular Surface Metagenome of Young Han Chinese From Beijing, Wenzhou, and Guangzhou Cities.

Authors:  Yuhua Deng; Xiaofeng Wen; Xiao Hu; Yanli Zou; Chan Zhao; Xuejiao Chen; Li Miao; Xifang Li; Xiuli Deng; Paul W Bible; Hongmin Ke; Jiahao Situ; Shixin Guo; Juanran Liang; Tingting Chen; Bin Zou; Yu Liu; Wei Chen; Kaili Wu; Meifen Zhang; Zi-Bing Jin; Lingyi Liang; Lai Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

6.  Antimicrobial Susceptibility Patterns and Resistance Trends of Staphylococcus aureus and Coagulase-Negative Staphylococci Strains Isolated from Ocular Infections.

Authors:  Francesco Petrillo; Danilo Pignataro; Federica Maria Di Lella; Michele Reibaldi; Matteo Fallico; Niccolò Castellino; Guglielmo Parisi; Maria Consiglia Trotta; Michele D'Amico; Biagio Santella; Veronica Folliero; Maria Teresa Della Rocca; Michele Rinaldi; Gianluigi Franci; Teresio Avitabile; Marilena Galdiero; Giovanni Boccia
Journal:  Antibiotics (Basel)       Date:  2021-05-03

7.  The effect of topical ocular moxifloxacin on conjunctival and nasal mucosal flora.

Authors:  Ali Riza Cenk Celebi; Ozlem Onerci Celebi
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

8.  Biofilm-Forming Potential of Ocular Fluid Staphylococcus aureus and Staphylococcus epidermidis on Ex Vivo Human Corneas from Attachment to Dispersal Phase.

Authors:  Ranjith Konduri; Chinthala Reddy Saiabhilash; Sisinthy Shivaji
Journal:  Microorganisms       Date:  2021-05-22

Review 9.  Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases.

Authors:  Rajeev K Pandey; Fu-Shin Yu; Ashok Kumar
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.